Procaps Group (NASDAQ:PROC) Shares Down 40.3% – Here’s What Happened

Shares of Procaps Group S.A. (NASDAQ:PROC) fell 40.3% during trading on Tuesday . The company traded as low as $0.77 and last traded at $0.95. 658,169 shares changed hands during trading, an increase of 1,406% from the average session volume of 43,715 shares. The stock had previously closed at $1.59.

Procaps Group Trading Down 40.3 %

The business’s 50 day moving average is $0.95 and its 200 day moving average is $1.44.

Institutional Investors Weigh In On Procaps Group

A hedge fund recently bought a new stake in Procaps Group stock. Itau Unibanco Holding S.A. purchased a new stake in Procaps Group S.A. (NASDAQ:PROC) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned approximately 0.16% of Procaps Group as of its most recent filing with the SEC.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.